Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 16
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT06220630 | The Characteristics, Treatment Patterns and Prognosis of Chinese Male Breast Cancer: A Real-world Study | ||
| NCT03727230 | RhD+ Blood Transfusion to Asian-type DEL Recipients | ||
| NCT02376894 | An Epidemiological Survey of Cancer-related Fatigue Among Taiwanese Cancer Patients | ||
| NCT05036486 | The Registry of Genetic Alterations of Taiwan Biliary Tract Cancer | ||
| NCT02654106 | Stereotactic Radiotherapy Plus Temozolomide for Refractory Brain Metastases | ||
| NCT03416699 | Chinese TaTME Registry Collaborative | ||
| NCT00201279 | Chemoprevention Study of Oral Cavity Squamous Cell Carcinoma | ||
| NCT02284490 | High-dose Pemetrexed to Treat Lung Adenocarcinoma With Brain Metastases | ||
| NCT05583838 | A Randomized Trial Comparing Optimized rhTPO Treatment With Eltrombopag Treatment in Pre-treated ITP Pts | ||
| NCT03544099 | Pembrolizumab for Nasopharyngeal Carcinoma Patients With Detectable Plasma Epstein-Barr Virus DNA | ||
| NCT01985451 | Pemetrexed and Temozolomide in Treating Patients With Relapsed Primary Central Nervous System Lymphoma （PCNSL） | ||
| NCT01441661 | Sunitinib Intake Conditions in the Treatment of Patients With Renal Cell Carcinoma | ||
| NCT00201383 | Post-Operative Adjuvant Concurrent Chemoradiotherapy For High Risk Oral Cavity Squamous Cell Carcinoma Patients | ||
| NCT05411705 | Efficacy and Safety of rhTPO's Prophylactic Treatment of CTIT in Patients With High Risk of Cardiac Injury | ||
| NCT01796288 | The Value of Radiotherapy in the Oligometastatic Non-squamous Non-small Cell Lung Cancer With Clinical Benefits From Erlotinib as Second-line Treatment | ||
| NCT01735747 | Temozolomide, Nedaplatin, Vincristine, and Radiotherapy as First-line Treatment in Newly Diagnosed Primary CNS Lymphoma |
